AAAAAA

   
Results: 1-15 |
Results: 15

Authors: Mahajan, AP Tashima, KT Bausserman, LL Flynn, MM Carpenter, CCJ
Citation: Ap. Mahajan et al., Plateau in body habitus changes and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy: A 3.5-year study, J ACQ IMM D, 28(4), 2001, pp. 332-335

Authors: Cu-Uvin, S Hogan, JW Caliendo, AM Harwell, J Mayer, KH Carpenter, CCJ
Citation: S. Cu-uvin et al., Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract, CLIN INF D, 33(6), 2001, pp. 894-896

Authors: Tashima, KT Hogan, JW Gardner, LI Korkontzelou, C Schoenbaum, EE Schuman, P Rompalo, A Carpenter, CCJ
Citation: Kt. Tashima et al., A longitudinal analysis of hospitalization and emergency department use among human immunodeficiency virus-infected women reporting protease inhibitor use, CLIN INF D, 33(12), 2001, pp. 2055-2060

Authors: Cohen, RA Boland, R Paul, R Tashima, KT Schoenbaum, EE Celentano, DD Schuman, P Smith, DK Carpenter, CCJ
Citation: Ra. Cohen et al., Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women, AIDS, 15(3), 2001, pp. 341-345

Authors: Phelps, RM Smith, DK Heilig, CM Gardner, LI Carpenter, CCJ Klein, RS Jamieson, DJ Vlahov, D Schuman, P Holmberg, SD
Citation: Rm. Phelps et al., Cancer incidence in women with or at risk for HIV, INT J CANC, 94(5), 2001, pp. 753-757

Authors: Stenzel, MS Carpenter, CCJ
Citation: Ms. Stenzel et Ccj. Carpenter, The management of the clinical complications of antiretroviral therapy, INF DIS CL, 14(4), 2000, pp. 851

Authors: Cu-Uvin, S Caliendo, AM Reinert, S Chang, A Juliano-Remollino, C Flanigan, TP Mayer, KH Carpenter, CCJ
Citation: S. Cu-uvin et al., Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA, AIDS, 14(4), 2000, pp. 415-421

Authors: Shacklett, BL Cu-Uvin, S Beadle, TJ Pace, CA Fast, NM Donahue, SM Caliendo, AM Flanigan, TP Carpenter, CCJ Nixon, DF
Citation: Bl. Shacklett et al., Quantification of HIV-1-specific T-cell responses at the mucosal cervicovaginal surface, AIDS, 14(13), 2000, pp. 1911-1915

Authors: Osowiecki, DM Cohen, RA Morrow, KM Paul, RH Carpenter, CCJ Flanigan, T Boland, RJ
Citation: Dm. Osowiecki et al., Neurocognitive and psychological contributions to quality of life in HIV-1-infected women, AIDS, 14(10), 2000, pp. 1327-1332

Authors: Harrington, M Carpenter, CCJ
Citation: M. Harrington et Ccj. Carpenter, Hit HIV-1 hard, but only when necessary, LANCET, 355(9221), 2000, pp. 2147-2152

Authors: Carpenter, CCJ Cooper, DA Fischl, MA Gatell, JM Gazzard, BG Hammer, SM Hirsch, MS Jacobsen, DM Katzenstein, DA Montaner, JSG Richman, DD Saag, MS Schechter, M Schooley, RT Vella, S Yeni, PG Volberding, PA
Citation: Ccj. Carpenter et al., Antiretroviral therapy in adults - Updated recommendations of the International AIDS Society-USA Panel, J AM MED A, 283(3), 2000, pp. 381-390

Authors: Carpenter, CCJ
Citation: Ccj. Carpenter, Effect of ritonavir on saquinavir metabolism, J AM MED A, 283(22), 2000, pp. 2937-2937

Authors: Dong, KL Bausserman, LL Flynn, MM Dickinson, BP Flanigan, TP Mileno, MD Tashima, KT Carpenter, CCJ
Citation: Kl. Dong et al., Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART), J ACQ IMM D, 21(2), 1999, pp. 107-113

Authors: Mitty, JA Mckenzie, M Stenzel, M Flanigan, T Carpenter, CCJ
Citation: Ja. Mitty et al., Modified directly observed therapy for treatment of human immunodeficiencyvirus, J AM MED A, 282(14), 1999, pp. 1334-1334

Authors: Rich, JD Merriman, NA Mylonakis, E Greenough, TC Flanigan, TP Mady, BJ Carpenter, CCJ
Citation: Jd. Rich et al., Misdiagnosis of HIV infection by HIV-1 plasma viral load testing: A case series, ANN INT MED, 130(1), 1999, pp. 37-39
Risultati: 1-15 |